ORIGINAL RESEARCH
Accepted on 14 Aug 2025
Safety and clinical outcomes of orelabrutinib, lenalidomide plus sintilimab for relapsed/refractory diffuse large B-cell lymphoma
doi 10.3389/fimmu.2025.1629224
- 139 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Precision Immunotherapy and Novel Target Discovery in Hematological Malignancy
Precision Immunotherapy and Novel Target Discovery in Hematological Malignancy
8,774
Total downloads
34k
Total views and downloads
Articles
BRIEF RESEARCH REPORT
Published on 17 Jul 2025
FLT3-ITD promotes immune checkpoint CD80 via ROS elevation in acute myeloid leukemia
doi 10.3389/fimmu.2025.1577313
- 890 views
ORIGINAL RESEARCH
Published on 10 Jun 2025
Protective effects for HLA-B*40:01 and C*03:04 in NPM1-mutated AML: result of a large HLA association study
doi 10.3389/fimmu.2025.1571508
- 1,439 views
BRIEF RESEARCH REPORT
Published on 29 May 2025
Drug repurposing of fostamatinib against cancer via potential cytotoxicity and immune checkpoint regulation
doi 10.3389/fimmu.2025.1602189
- 1,605 views
ORIGINAL RESEARCH
Published on 17 Apr 2025
Multiplex immunophenotyping of human acute myeloid leukemia patients revealed single -cell heterogeneity with special attention on therapy sensitive and therapy resistant subpopulations
doi 10.3389/fimmu.2025.1563386
- 2,160 views
REVIEW
Published on 07 Apr 2025
Mechanisms of HDACs in cancer development
doi 10.3389/fimmu.2025.1529239
- 3,172 views
- 3 citations
REVIEW
Published on 01 Apr 2025
In the era of targeted therapy and immunotherapy: advances in the treatment of large B-cell lymphoma of immune-privileged sites
doi 10.3389/fimmu.2025.1547377
- 1,605 views
ORIGINAL RESEARCH
Published on 31 Mar 2025
Impact of single nucleotide polymorphisms of immunomodulatory factors on treatment response and prognosis in acute myeloid leukemia
doi 10.3389/fimmu.2025.1571332
- 1,310 views
ORIGINAL RESEARCH
Published on 25 Feb 2025
Raman spectroscopy and bioinformatics-based identification of key genes and pathways capable of distinguishing between diffuse large B cell lymphoma and chronic lymphocytic leukemia
doi 10.3389/fimmu.2025.1516946
- 1,723 views
ORIGINAL RESEARCH
Published on 20 Feb 2025
Aclacinomycin enhances the killing effect of allogeneic NK cells on acute myeloid leukemia cells by inducing immunogenic cell death
doi 10.3389/fimmu.2025.1521939
- 1,163 views
- 1 citation
CASE REPORT
Published on 14 Jan 2025
Case report: The case of T-cell acute lymphoblastic leukemia treated with chemotherapy followed by anti-CD7 CAR-T cells using retroviral vector
doi 10.3389/fimmu.2024.1519055
- 2,594 views
- 1 citation
ORIGINAL RESEARCH
Published on 13 Jan 2025
In vitro functional validation of anti-CD19 chimeric antigen receptor T cells expressing lysine-specific demethylase 1 short hairpin RNA for the treatment of diffuse large B cell lymphoma
doi 10.3389/fimmu.2024.1521778
- 2,395 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore